| 698248 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
High-Impact Clinical Studies That Fomented New Developments in Anesthesia: History of Achievements, 1966–2015 |
2021-06-01 |
10.2147/dddt.s316636 |
Kissin Igor |
| 698247 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Ursolic Acid Reduces the Metalloprotease/Anti-Metalloprotease Imbalance in Cerebral Ischemia and Reperfusion Injury [Corrigendum] |
2021-06-01 |
10.2147/dddt.s318620 |
Wang Yanzhe, He Zhiyi, Deng Shumin |
| 698246 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions |
2021-06-01 |
10.2147/dddt.s304108 |
Li Qiuying, Jia Lihui, Hu Wenli, Dong Shu, Cai Chaohong |
| 698245 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Sulfasalazine Inhibits Inflammation and Fibrogenesis in Pancreas via NF-κB Signaling Pathway in Rats with Oxidative Stress-Induced Pancreatic Injury [Corrigendum] |
2021-06-01 |
10.2147/dddt.s324356 |
Wang Ya-Ru, Tian Fei-Long, Yan Ming-Xian, Fan Jin-Hua, Wang Li-Yun, Kuang Rong-Guang, Li Yan-Qing |
| 698244 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Multiple Administrations of Itraconazole Increase Plasma Exposure to Pyrotinib in Chinese Healthy Adults |
2021-06-01 |
10.2147/dddt.s312310 |
Liu Yueyue, Zhang Qian, Lu Chao, Hu Wei |
| 698243 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Current Evidence for the Use of Safinamide for the Treatment of Parkinson’s Disease |
2021-06-01 |
10.2147/dddt.s302673 |
Abbruzzese Giovanni, Barone Paolo, Lopiano Leonardo, Stocchi Fabrizio |
| 698242 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Immunoregulatory Effect of Acanthopanax trifoliatus (L.) Merr. Polysaccharide on T1DM Mice |
2021-06-01 |
10.2147/dddt.s309851 |
Li Ping, Chen Yanli, Luo Luxiang, Yang Huiwen, Pan Yufang |
| 698241 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis |
2021-06-01 |
10.2147/dddt.s310163 |
Li Jingjing, Guo Chuanyong, Wu Jianye |
| 698240 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Simultaneous Determination of Celecoxib, Dezocine and Dexmedetomidine in Beagle Plasma Using UPLC-MS/MS Method and the Application in Pharmacokinetics |
2021-06-01 |
10.2147/dddt.s314562 |
Hu Jie, Su Xin-juan, Si Hui-Ling, Song Rui-Xiang, Zhang Fang, Qiu Xiang-Jun, Chen Xing-peng |
| 698239 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Stability of Aprepitant Injectable Emulsion in Alternate Infusion Bags, in Refrigerated Storage, and Admixed with Dexamethasone and Palonosetron |
2021-06-01 |
10.2147/dddt.s282058 |
Ottoboni Thomas, Lerner Laura, Santhouse Arlene |
